Trying to remember: Immunological B cell memory to malaria

Trends in Parasitology

Volumn 31, Issue 3, 2015, Pages 89-94

  Hviid, Lars ^a   Barfod, Lea ^a   Fowkes, Freya J I ^b,c,d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b BURNET INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; PROTOZOON ANTIBODY;

AGE; ANTIBODY RESPONSE; B LYMPHOCYTE; HUMAN; IMMUNITY; IMMUNOLOGICAL MEMORY; LONGEVITY; MALARIA; MEMORY CELL; NONHUMAN; PARASITE; PLASMODIUM; PLASMODIUM FALCIPARUM; REVIEW; ANTIBODY PRODUCTION; IMMUNOLOGY; MALARIA FALCIPARUM;

PLASMODIUM FALCIPARUM;

AGE FACTORS; ANTIBODIES, PROTOZOAN; ANTIBODY FORMATION; B-LYMPHOCYTES; HUMANS; IMMUNOLOGIC MEMORY; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

EID: 84924699635     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2014.12.009     Document Type: Review

References (73)

1. Cohen S., et al. Gammaglobulin and acquired immunity to human malaria. Nature 1961, 192:733-737.
2. Hoffman S.L., et al. Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications. Science 1987, 237:639-642.
3. Cowman A.F., Crabb B.S. Invasion of red blood cells by malaria parasites. Cell 2006, 124:755-766.
4. Chan J.A., et al. Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates. Cell. Mol. Life Sci. 2014, 71:3633-3657.
5. Fried M., et al. Maternal antibodies block malaria. Nature 1998, 395:851-852.
6. Wilson D.W., et al. Quantifying the importance of MSP1-19 as a target of growth-inhibitory and protective antibodies against Plasmodium falciparum in humans. PLoS ONE 2011, 6:e27705.
7. Persson K.E., et al. Erythrocyte-binding antigens of Plasmodium falciparum are targets of human inhibitory antibodies and function to evade naturally acquired immunity. J. Immunol. 2013, 191:785-794.
8. Bouharoun-Tayoun H., et al. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 1990, 172:1633-1641.
9. Biryukov S., Stoute J.A. Complement activation in malaria: friend or foe?. Trends Mol. Med. 2014, 20:293-301.
10. Osier F.H., et al. Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria. BMC Med. 2014, 12:108.
11. Doolan D.L., et al. Acquired immunity to malaria. Clin. Microbiol. Rev. 2009, 22:13-36.
12. Urban B.C., et al. Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 1999, 400:73-77.
13. Donati D., et al. Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect. Immun. 2004, 72:5412-5418.
14. Barfod L., et al. Evasion of immunity to Plasmodium falciparum malaria by IgM masking of protective IgG epitopes in infected erythrocyte surface-exposed PfEMP1. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:12485-12490.
15. Crompton P.D., et al. Sickle cell trait is associated with a delayed onset of malaria: implications for time-to-event analysis in clinical studies of malaria. J. Infect. Dis. 2008, 198:1265-1275.
16. Males S., et al. Long-term asymptomatic carriage of Plasmodium falciparum protects from malaria attacks: a prospective study among Senegalese children. Clin. Infect. Dis. 2008, 46:516-522.
17. Owusu-Agyei S., et al. Does radical cure of asymptomatic Plasmodium falciparum place adults in endemic areas at increased risk of recurrent symptomatic malaria?. Trop. Med. Int. Health 2002, 7:599-603.
18. Crompton P.D., et al. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:6958-6963.
19. Struik S.S., Riley E.M. Does malaria suffer from lack of memory?. Immunol. Rev. 2004, 201:268-290.
20. Kinyanjui S.M., et al. Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens. J. Infect. Dis. 2003, 187:667-674.
21. Kinyanjui S.M., et al. IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar. J. 2007, 6:82.
22. Portugal S., et al. Young lives lost as B cells falter: what we are learning about antibody responses in malaria. J. Immunol. 2013, 190:3039-3046.
23. Weiss G.E., et al. Atypical memory B Cells are greatly expanded in individuals living in a malaria-endemic area. J. Immunol. 2009, 183:2176-2182.
24. Smith K.G., et al. The phenotype and fate of the antibody-forming cells of the splenic foci. Eur. J. Immunol. 1996, 26:444-448.
25. Manz R.A., et al. Lifetime of plasma cells in the bone marrow. Nature 1997, 388:133-134.
26. Slifka M.K., et al. Humoral immunity due to long-lived plasma cells. Immunity 1998, 8:363-372.
27. Ofori M.F., et al. Malaria-induced acquisition of antibodies to Plasmodium falciparum variant surface antigens. Infect. Immun. 2002, 70:2982-2988.
28. Akpogheneta O.J., et al. Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect. Immun. 2008, 76:1748-1755.
29. Wipasa J., et al. Long-lived antibody and B cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax. PLoS Pathog. 2010, 6:e1000770.
30. Dorfman J.R., et al. B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area. J. Infect. Dis. 2005, 191:1623-1630.
31. Ndungu F.M., et al. Long-lived Plasmodium falciparum specific memory B cells in naturally exposed Swedish travellers. Eur. J. Immunol. 2013, 43:2919-2929.
32. Ampomah P., et al. B-cell responses to pregnancy-restricted and -unrestricted Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) antigens in Ghanaian women naturally exposed to malaria parasites. Infect. Immun. 2014, 82:1860-1871.
33. White M.T., et al. Dynamics of the antibody response to Plasmodium falciparum infection in African children. J. Infect. Dis. 2014, 210:1115-1122.
34. Murungi L.M., et al. A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria. Vaccine 2013, 31:3936-3942.
35. Dups J.N., et al. Antibody and B cell responses to Plasmodium sporozoites. Front. Microbiol. 2014, 5:625.
36. Fried M., Duffy P.E. Adherence of Plasmodium falciparum to chondroitin sulphate A in the human placenta. Science 1996, 272:1502-1504.
37. Muthusamy A., et al. Plasmodium falciparum-infected erythrocytes adhere both in the intervillous space and on the villous surface of human placenta by binding to the low-sulfated chondroitin sulfate proteoglycan receptor. Am. J. Pathol. 2004, 164:2013-2025.
38. Salanti A., et al. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J. Exp. Med. 2004, 200:1197-1203.
39. Hviid L. The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria. Expert. Rev. Vaccines. 2011, 10:1405-1414.
40. Staalsoe T., et al. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum infected erythrocytes that are associated with protection against placental parasitemia. J. Infect. Dis. 2001, 184:618-626.
41. Aitken E.H., et al. Antibodies to chondroitin sulfate A-binding infected erythrocytes: dynamics and protection during pregnancy in women receiving intermittent preventive treatment. J. Infect. Dis. 2010, 201:1316-1325.
42. O'Neil-Dunne I., et al. Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy. Infect. Immun. 2001, 69:7487-7492.
43. Fowkes F.J., et al. Antibody boosting and longevity following tetanus immunization during pregnancy. Clin. Infect. Dis. 2013, 56:749-750.
44. Ampomah P., et al. Kinetics of B cell responses to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) in Ghanaian women naturally exposed to malaria parasites. J. Immunol. 2014, 192:5236-5244.
45. Fowkes F.J., et al. New insights into acquisition, boosting and longevity of immunity to malaria in pregnant women. J. Infect. Dis. 2012, 206:1612-1621.
46. Ndungu F.M., et al. Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:8247-8252.
47. Nahrendorf W., et al. Memory B-cell and antibody responses induced by Plasmodium falciparum sporozoite immunization. J. Infect. Dis. 2014, 210:1981-1990.
48. Osier F.H., et al. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect. Immun. 2008, 76:2240-2248.
49. Rono J., et al. Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria. Clin. Infect. Dis. 2013, 57:1409-1416.
50. Staalsoe T., et al. In vivo switching between variant surface antigens in human Plasmodium falciparum infection. J. Infect. Dis. 2002, 186:719-722.
51. Nunes M.C., et al. Investigation of host factors possibly enhancing the emergence of the chondroitin sulfate A-binding phenotype in Plasmodium falciparum. Microbes Infect. 2008, 10:828-832.
52. Lavstsen T., et al. Expression of Plasmodium falciparum erythrocyte membrane protein 1 in experimentally infected humans. Malar. J. 2005, 4:21.
53. Wang C.W., et al. The Plasmodium falciparum var gene transcription strategy at the onset of blood stage infection in a human volunteer. Parasitol. Int. 2009, 58:478-480.
54. Lines J., Armstrong J.R.M. For a few parasites more: inoculum size, vector control and strain-specific immunity to malaria. Parasitol. Today 1992, 8:381-383.
55. Collins W.E., Jeffery G.M. A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity during primary infection. Am. J. Trop. Med. Hyg. 1999, 61:4-19.
56. Greenwood T., et al. Febrile Plasmodium falciparum malaria 4 years after exposure in a man with sickle cell disease. Clin. Infect. Dis. 2008, 47:e39-e41.
57. Szmitko P.E., et al. Plasmodium falciparum malaria occurring 8 years after leaving an endemic area. Diagn. Microbiol. Infect. Dis. 2009, 63:105-107.
58. Theunissen C., et al. Falciparum malaria in patient 9 years after leaving malaria-endemic area. Emerg. Infect. Dis. 2009, 15:115-116.
59. Berrevoets M.A., et al. Plasmodium falciparum malaria recrudescence occurring 2.5 years after leaving an endemic country. Neth. J. Med. 2013, 71:426-428.
60. Früh K., et al. Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short-lived. Infect. Immun. 1991, 59:1319-1324.
61. Giha H.A., et al. Nine-year longitudinal study of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes. Infect. Immun. 1999, 67:4092-4098.
62. Ehrhardt G.R., et al. Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J. Exp. Med. 2005, 202:783-791.
63. Moir S., et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J. Exp. Med. 2008, 205:1797-1805.
64. Weiss G.E., et al. The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections. PLoS. Pathog. 2010, 6:e1000912.
65. Weiss G.E., et al. A positive correlation between atypical memory B cells and Plasmodium falciparum transmission intensity in cross-sectional studies in Peru and Mali. PLoS ONE 2011, 6:e15983.
66. Clark E.H., et al. Plasmodium falciparum malaria in the low transmission Peruvian Amazon is associated with immunologic memory. Infect. Immun. 2012, 80:1583-1592.
67. Ayieko C., et al. Changes in B cell populations and merozoite surface protein-1-specific memory B cell responses after prolonged absence of detectable infection. PLoS ONE 2013, 8:e67230.
68. Illingworth J., et al. Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion. J. Immunol. 2013, 190:1038-1047.
69. Requena P., et al. Pregnancy and malaria exposure are associated with changes in the B cell pool and in plasma eotaxin levels. J. Immunol. 2014, 193:2971-2983.
70. Muellenbeck M.F., et al. Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies. J. Exp. Med. 2013, 210:389-399.
71. Asito A.S., et al. Alterations on peripheral B cell subsets following an acute uncomplicated clinical malaria infection in children. Malar. J. 2008, 7:238.
72. Elias S.C., et al. Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection. Immunology 2014, 141:628-644.
73. Scholzen A., et al. BAFF and BAFF receptor levels correlate with B cell subset activation and redistribution in controlled human malaria infection. J. Immunol. 2014, 192:3719-3729.